Trexquant Investment LP Mirati Therapeutics, Inc. Transaction History

Trexquant Investment LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $709,002 - $1.03 Million	11,916 Added 220.14%	17,329 $1.21 Million
Q2 2022 Aug 11, 2022	SELL	$39.16 - $88.71 $811,042 - $1.84 Million	-20,711 Reduced 79.28%	5,413 $363,000
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $1.78 Million - $3.54 Million	23,435 Added 871.51%	26,124 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $354,974 - $511,689	2,689 New	2,689 $394,000
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $640,830 - $860,632	-4,850 Closed	0 $0

Q2 2021 Aug 12, 2021	BUY	$144.0 - $179.73 $698,400 - $871,690	4,850 New	4,850 $783,000
Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $1.55 Million - $2.16 Million	-9,742 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$162.05 - $240.27 $1.58 Million - $2.34 Million	9,742 New	9,742 $2.14 Million
Q4 2019 Feb 12, 2020	SELL	$70.76 - $128.86 $613,135 - $1.12 Million	-8,665 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$77.91 - $109.6 $389,939 - $548,548	5,005 Added 136.75%	8,665 $675,000
Q2 2019 Aug 09, 2019	BUY	$59.49 - $104.71 $217,733 - $383,238	3,660 New	3,660 $377,000
Q1 2019 May 13, 2019	SELL	$43.65 - $78.95 $303,978 - $549,807	-6,964 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $222,848 - $330,302	6,964 New	6,964 $295,000
Q2 2018 Aug 07, 2018	SELL	$26.05 - $52.4 $694,232 - $1.4 Million	-26,650 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$17.2 - $34.95 $458,380 - $931,417	26,650 New	26,650 $818,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.